Neuroendocrine differentiation is an independent prognostic factor in chemotherapy-treated nonsmall cell lung carcinoma

Jeffrey T. Schleusener, Henry D. Tazelaar, Sin‐Ho Jung, S. Stephen, J. Peter, Jeffrey L. Myers, Edward T. Creagan, Richard M. Goldberg, Robert F. Marschke

Cancer · 1996 · 107 citations · 26 references

DOIFull text

Open access

Abstract

Neuroendocrine differentiation may be of prognostic significance in patients with advanced stage NSCLC treated with chemotherapy.

References

26